Direct oral anticoagulant- vs vitamin K antagonist-related
nontraumatic intracerebral hemorrhage

J 2017

Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage

TSIVGOULIS, G.; V. A. LIOUTAS; P. VARELAS; A. H. KATSANOS; N. GOYAL et al.

Základní údaje

Originální název

Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage

Autoři

Vydání

Neurology, Philadelphia, LIPPINCOTT WILLIAMS & WILKINS, 2017, 0028-3878

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30103 Neurosciences

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 8.055

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/17:00118137

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

Direct oral anticoagulant; nontraumatic intracerebral hemorrhage; vitamin K

Štítky

rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 9. 2. 2021 07:50, Mgr. Tereza Miškechová

Anotace

V originále

Objective: To compare the neuroimaging profile and clinical outcomes among patients with intracerebral hemorrhage (ICH) related to use of vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) for nonvalvular atrial fibrillation (NVAF). Methods: We evaluated consecutive patients with NVAF with nontraumatic, anticoagulantrelated ICH admitted at 13 tertiary stroke care centers over a 12-month period. We also performed a systematic review and meta-analysis of eligible observational studies reporting baseline characteristics and outcomes among patients with VKA-or DOAC-related ICH. Results: We prospectively evaluated 161 patients with anticoagulation-related ICH (mean age 75.6 +/- 9.8 years, 57.8% men, median admission NIH Stroke Scale [NIHSSadm] score 13 points, interquartile range 6-21). DOAC-related (n = 47) and VKA-related (n = 114) ICH did not differ in demographics, vascular risk factors, HAS-BLED and CHA(2)DS(2)-VASc scores, and antiplatelet pretreatment except for a higher prevalence of chronic kidney disease in VKA-related ICH. Patients with DOAC-related ICH had lower median NIHSSadm scores (8 [3-14] vs 15 [7-25] points, p = 0.003), median baseline hematoma volume (12.8 [4-40] vs 24.3 [11-58.8] cm(3), p = 0.007), and median ICH score (1 [0-2] vs 2 [1-3] points, p = 0.049). Severe ICH (> 2 points) was less prevalent in DOAC-related ICH (17.0% vs 36.8%, p = 0.013). In multivariable analyses, DOAC-related ICH was independently associated with lower baseline hematoma volume (p = 0.006), lower NIHSSadm scores (p = 0.022), and lower likelihood of severe ICH (odds ratio [OR] 0.34, 95% confidence interval [CI] 0.13-0.87, p = 0.025). In meta-analysis of eligible studies, DOAC-related ICH was associated with lower baseline hematoma volumes on admission CT (standardized mean difference 5 20.57, 95% CI 21.02 to 20.12, p = 0.010) and lower in-hospital mortality rates (OR = 0.44, 95% CI 0.21-0.91, p = 0.030). Conclusions: DOAC-related ICH is associated with smaller baseline hematoma volume and lesser neurologic deficit at hospital admission compared to VKA-related ICH.

Návaznosti

LM2015090, projekt VaV

Název: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Akronym: CZECRIN)

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, CZECRIN - Český národní uzel Evropské sítě infrastruktur klinického výzkumu

Citovat

TSIVGOULIS, G.; V. A. LIOUTAS; P. VARELAS; A. H. KATSANOS; N. GOYAL; Robert MIKULÍK; K. BARLINN; C. KROGIAS; V. K. SHARMA; K. VADIKOLIAS; E. DARDIOTIS; T. KARAPANAYIOTIDES; A. PAPPA; C. ZOMPOLA; S. TRIANTAFYLLOU; O. KARGIOTIS; M. IOAKEIMIDIS; S. GIANNOPOULOS; A. KERRO; A. TSANTES; C. MEHTA; M. JONES; C. SCHROEDER; C. NORTON; A. BONAKIS; J. CHANG; A .W. ALEXANDROV; P. MITSIAS a A. V. ALEXANDROV. Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage. Neurology. Philadelphia: LIPPINCOTT WILLIAMS & WILKINS, 2017, roč. 89, č. 11, s. 1142-1151. ISSN 0028-3878. Dostupné z: https://doi.org/10.1212/WNL.0000000000004362.

@article{1739837,
   author = {Tsivgoulis, G. and Lioutas, V. A. and Varelas, P. and Katsanos, A. H. and Goyal, N. and Mikulík, Robert and Barlinn, K. and Krogias, C. and Sharma, V. K. and Vadikolias, K. and Dardiotis, E. and Karapanayiotides, T. and Pappa, A. and Zompola, C. and Triantafyllou, S. and Kargiotis, O. and Ioakeimidis, M. and Giannopoulos, S. and Kerro, A. and Tsantes, A. and Mehta, C. and Jones, M. and Schroeder, C. and Norton, C. and Bonakis, A. and Chang, J. and Alexandrov, A .W. and Mitsias, P. and Alexandrov, A. V.},
   article_location = {Philadelphia},
   article_number = {11},
   doi = {https://doi.org/10.1212/WNL.0000000000004362},
   keywords = {Direct oral anticoagulant; nontraumatic intracerebral hemorrhage; vitamin K},
   language = {eng},
   issn = {0028-3878},
   journal = {Neurology},
   title = {Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage},
   url = {https://n.neurology.org/content/89/11/1142},
   volume = {89},
   year = {2017}
}

TY  - JOUR
ID  - 1739837
AU  - Tsivgoulis, G. - Lioutas, V. A. - Varelas, P. - Katsanos, A. H. - Goyal, N. - Mikulík, Robert - Barlinn, K. - Krogias, C. - Sharma, V. K. - Vadikolias, K. - Dardiotis, E. - Karapanayiotides, T. - Pappa, A. - Zompola, C. - Triantafyllou, S. - Kargiotis, O. - Ioakeimidis, M. - Giannopoulos, S. - Kerro, A. - Tsantes, A. - Mehta, C. - Jones, M. - Schroeder, C. - Norton, C. - Bonakis, A. - Chang, J. - Alexandrov, A .W. - Mitsias, P. - Alexandrov, A. V.
PY  - 2017
TI  - Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage
JF  - Neurology
VL  - 89
IS  - 11
SP  - 1142-1151
EP  - 1142-1151
PB  - LIPPINCOTT WILLIAMS & WILKINS
SN  - 00283878
KW  - Direct oral anticoagulant
KW  - nontraumatic intracerebral hemorrhage
KW  - vitamin K
UR  - https://n.neurology.org/content/89/11/1142
L2  - https://n.neurology.org/content/89/11/1142
N2  - Objective: To compare the neuroimaging profile and clinical outcomes among patients with intracerebral hemorrhage (ICH) related to use of vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) for nonvalvular atrial fibrillation (NVAF). Methods: We evaluated consecutive patients with NVAF with nontraumatic, anticoagulantrelated ICH admitted at 13 tertiary stroke care centers over a 12-month period. We also performed a systematic review and meta-analysis of eligible observational studies reporting baseline characteristics and outcomes among patients with VKA-or DOAC-related ICH. Results: We prospectively evaluated 161 patients with anticoagulation-related ICH (mean age 75.6 +/- 9.8 years, 57.8% men, median admission NIH Stroke Scale [NIHSSadm] score 13 points, interquartile range 6-21). DOAC-related (n = 47) and VKA-related (n = 114) ICH did not differ in demographics, vascular risk factors, HAS-BLED and CHA(2)DS(2)-VASc scores, and antiplatelet pretreatment except for a higher prevalence of chronic kidney disease in VKA-related ICH. Patients with DOAC-related ICH had lower median NIHSSadm scores (8 [3-14] vs 15 [7-25] points, p = 0.003), median baseline hematoma volume (12.8 [4-40] vs 24.3 [11-58.8] cm(3), p = 0.007), and median ICH score (1 [0-2] vs 2 [1-3] points, p = 0.049). Severe ICH (> 2 points) was less prevalent in DOAC-related ICH (17.0% vs 36.8%, p = 0.013). In multivariable analyses, DOAC-related ICH was independently associated with lower baseline hematoma volume (p = 0.006), lower NIHSSadm scores (p = 0.022), and lower likelihood of severe ICH (odds ratio [OR] 0.34, 95% confidence interval [CI] 0.13-0.87, p = 0.025). In meta-analysis of eligible studies, DOAC-related ICH was associated with lower baseline hematoma volumes on admission CT (standardized mean difference 5 20.57, 95% CI 21.02 to 20.12, p = 0.010) and lower in-hospital mortality rates (OR = 0.44, 95% CI 0.21-0.91, p = 0.030). Conclusions: DOAC-related ICH is associated with smaller baseline hematoma volume and lesser neurologic deficit at hospital admission compared to VKA-related ICH.
ER  -

TSIVGOULIS, G.; V. A. LIOUTAS; P. VARELAS; A. H. KATSANOS; N. GOYAL; Robert MIKULÍK; K. BARLINN; C. KROGIAS; V. K. SHARMA; K. VADIKOLIAS; E. DARDIOTIS; T. KARAPANAYIOTIDES; A. PAPPA; C. ZOMPOLA; S. TRIANTAFYLLOU; O. KARGIOTIS; M. IOAKEIMIDIS; S. GIANNOPOULOS; A. KERRO; A. TSANTES; C. MEHTA; M. JONES; C. SCHROEDER; C. NORTON; A. BONAKIS; J. CHANG; A .W. ALEXANDROV; P. MITSIAS a A. V. ALEXANDROV. Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage. \textit{Neurology}. Philadelphia: LIPPINCOTT WILLIAMS \&{} WILKINS, 2017, roč.~89, č.~11, s.~1142-1151. ISSN~0028-3878. Dostupné z: https://doi.org/10.1212/WNL.0000000000004362.

Přehled o publikaci